MicroRNA–mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients

Cytarabine is the primary chemotherapeutic agent used for treatment of acute myeloid leukemia (AML). Disease relapse after initial remission remains one of the most pressing therapeutic challenges in the treatment of AML. Relapsed disease is often resistant to cytarabine and subsequent salvage thera...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Pharmacol
Huvudupphovsmän: Bhise, Neha S., Chauhan, Lata, Shin, Miyoung, Cao, Xueyuan, Pounds, Stanley, Lamba, Vishal, Lamba, Jatinder K.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2016
Ämnen:
Pharmacology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4729948/
https://ncbi.nlm.nih.gov/pubmed/26858643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2015.00324
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk